![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/00 | |
A61K 31/7076 | |||
A61K 31/519 | |||
A61P 19/02 |
(11) | Number of the document | 1959939 |
(13) | Kind of document | T |
(96) | European patent application number | 06821594.6 |
Date of filing the European patent application | 2006-11-29 | |
(97) | Date of publication of the European application | 2008-08-27 |
(45) | Date of publication and mention of the grant of the patent | 2012-01-11 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/IL2006/001374 |
Date | 2006-11-29 |
(87) | Number | WO 2007/063538 |
Date | 2007-06-07 |
(30) | Number | Date | Country code |
740631 P | 2005-11-30 | US |
(72) |
FISHMAN, Pnina, IL
|
(73) |
Can-Fite Biopharma Ltd.,
10 Bareket Street P.O. Box 7537, Petach Tikva 49170,
IL
|
(54) | USE OF A3 ADENOSINE RECEPTOR AGONIST IN OSTEOARTHRITIS TREATMENT |
USE OF A3 ADENOSINE RECEPTOR AGONIST IN OSTEOARTHRITIS TREATMENT |